Oral and dental management for head and neck cancer patients treated by chemotherapy and radiotherapy

Dental Update

Volumn 39, Issue 2, 2012, Pages 135-140

  McCaul, Lorna K ^a  

^a BRADFORD TEACHING HOSPITALS NHS FOUNDATION TRUST   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ARTICLE; BONE NECROSIS; CASE REPORT; CHEMORADIOTHERAPY; DENTAL CARIES; DENTAL PROCEDURE; DYSPHAGIA; FEMALE; GENERAL PRACTICE; HEAD AND NECK TUMOR; HUMAN; METHODOLOGY; MUCOSA INFLAMMATION; PATIENT CARE; POSTOPERATIVE CARE; PREOPERATIVE CARE; SKULL IRRADIATION; STOMATITIS; TRISMUS; XEROSTOMIA;

ADULT; CHEMORADIOTHERAPY; CRANIAL IRRADIATION; DEGLUTITION DISORDERS; DENTAL CARE; DENTAL CARIES; FEMALE; GENERAL PRACTICE, DENTAL; HEAD AND NECK NEOPLASMS; HUMANS; MUCOSITIS; OSTEORADIONECROSIS; PATIENT CARE TEAM; POSTOPERATIVE CARE; PREOPERATIVE CARE; STOMATITIS; TRISMUS; XEROSTOMIA;

EID: 84859927969     PISSN: 03055000     EISSN: None     Source Type: Journal    
DOI: 10.12968/denu.2012.39.2.135     Document Type: Article

References (13)

1. National Head and Neck Cancer Audit 6th Annual Report (amended). Ref. No. 16050111. 2011.
2. National Institute for Health and Clinical Excellence (NICE). Improving Outcomes in Head and Neck Cancer. November 2004.
3. Scottish Intercollegiate Guidelines Network.Diagnosis and Management of Head and Neck Cancer. SIGN 90. October 2006.
4. Blanchard P, Baujat B, Holostenco V, Bourredjem A, Baey C, Bourhis J, Pignon JP: MACH-CH Collaborative group. Metaanalysis of chemotherapy in head and neck cancer (MACH-NC): a comprehensive analysis by tumour site. Radiother Oncol 2011 Jul; 100(1): 33-40. Epub 2011, Jun 16.
5. Nutting CM, Morden JP, Harrington KJ et al. Parotid-sparing intensity modulated radiotherapy in head and neck cancer (PARSPORT): a phase 3 multicentre randomized controlled trial. Lancet Oncology 2011; 12(2): 127-136.
6. Fakhry C, Westra WH, Li S, Cmelak A, Ridge JA, Pinto H, Forastiere A, Gillison ML. Improved survival of patients with human papillomavirus-positive head and neck squamous cell carcinoma in a prospective clinical trial. J Natl Cancer Inst 2008; 100: 261-269.
7. Porter SR, Fedele S, Habbab KM. Xerostomia in head and neck malignancy. Oral Oncol 2010; 46(6): 460-463.
8. Scott B, Butterworth C, Lowe D, Rogers SN. Factors associated with restricted mouth opening and its relationship to healthrelated quality of life in patients attending a Maxillofacial Oncology clinic. Oral Oncol 2008; 44(5): 430-438.
9. Bese NS, Hendry J, Jeremic B. Effects of prolongation of overall treatment time due to unplanned interruptions during radiotherapy of different tumor sites and practical methods for compensation. Int J Radiat Oncol Biol Phys 2007; 68(3): 654-661.
10. Lyons AJ, West CM, Risk JM et al. Osteoradionecrosis in head and neck cancer has a distinct genotype-dependent cause. Int J Radiat Oncol Biol Phys 2011 Jun; 25: epub ahead of print.
11. Epstein JB, Silverman S, Jr, Paggiarino DA, Crockett S, Schubert MM, Senzer NN et al. Benzydamine HCl for prophylaxis of radiation-induced oral mucositis: results from a multicenter, randomised, doubleblind, placebo controlled clinical trial. Cancer 2001; 92(4): 875-885.
12. Bondestan O, Gahnberg L. Effect of chlorhexidine gel on the prevalence of mutans streptococci and lactobacilli. Spec Care Dent 1996; 16: 123-128.
13. Strietzel FP, Martin-Granzio R, Fedele S et al. Electrostimulating device in the management of xerostomia. Oral Dis 2007; 13(2): 206-213.